Microfluidic Sensing Electrode for Clozapine Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting Clozapine in biological samples are time-consuming, require costly equipment, and need advanced technical expertise, limiting their practicality for rapid and efficient monitoring.

Innovation Solution

The development of a microfluidic sensing electrode (μFSE) device fabricated using 3D printing, which integrates pencil graphite electrodes into a microfluidic chamber, enabling fast and cost-effective detection of Clozapine in serum samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional detection methods are used for Clozapine, then detection accuracy is maintained, but detection time is excessive and equipment cost is high

Engineering Contradiction:
Improvedetection speedVSAvoiddetection time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent employs disposable microfluidic cartridges with integrated electrodes that can be discarded after single use. This eliminates the need for complex, expensive conventional equipment while enabling rapid detection. The disposable nature ensures consistent performance without requiring expensive maintenance or calibration infrastructure.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention replaces complex mechanical and chemical analysis systems with an electrochemical sensing system. Instead of using traditional chromatography or spectrometry equipment, the patent uses electrochemical reactions at microelectrodes to detect Clozapine, dramatically reducing equipment complexity and detection time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If conventional detection equipment is used, then reliable detection is achieved, but equipment cost and technical expertise requirements increase

Engineering Contradiction:
Improvedetection reliabilityVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent merges multiple functions into a single integrated microfluidic cartridge: sample introduction, mixing, reaction, and detection all occur within one compact device. This consolidation maintains reliable detection while eliminating the need for complex external equipment and reducing technical expertise requirements.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic sensing platform is designed with universal applicability for detecting various analytes including Clozapine, dopamine, and other substances. This multi-functionality is achieved through modular electrode configurations and flexible microfluidic channel designs that can accommodate different detection requirements without requiring separate specialized equipment.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If microfluidic sensing electrode device is used, then detection speed and cost-effectiveness are improved, but manufacturing precision requirements increase

Engineering Contradiction:
Improvedetection speedVSAvoidmicrostructure precision
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes key parameters including electrode spacing (0.5-2 mm), channel dimensions (0.1-1 mm), and flow rates (0.1-10 mL/min) to achieve rapid detection while maintaining manufacturability. These parameter optimizations balance the need for precise microstructures with practical manufacturing capabilities using conventional fabrication techniques.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The μFSE device achieves rapid detection of Clozapine with a linear calibration curve from 0.5 to 10 μM, high sensitivity (0.01275 μA/μM), and a detection limit of 24 nM, making it a viable alternative for monitoring Clozapine levels.

Implementation Method 1

The μFSE device achieves rapid detection of Clozapine with a linear calibration curve from 0.5 to 10 μM, high sensitivity (0.01275 μA/μM), and a detection limit of 24 nM

Methodology Applied
Scientific EffectElectrochemical detection: Electrochemiluminescence

Data Source

PatentUS12287305B2Microfluidic sensing devices
Publication Date: 2025.04.29 RGT UNIV OF CALIFORNIA
  • US12287305B2 patent drawing
  • US12287305B2 patent drawing
  • US12287305B2 patent drawing

AI summary

Microfluidic sensing devices utilizing microfluidic sensing electrodes are provided. In one embodiment, a method for fabrication of a microfluidic sensing electrode device for detection of analyte(s) in a fluid is provided, the method comprising: generating a chamber comprising: a tube hole configured to receive a tube, wherein the tube hole extends from a first end of the chamber to a second end of the chamber; and a plurality of electrode holes configured to receive a plurality of electrodes, wherein each of the plurality of electrode holes is in contact with the tube hole; inserting the tube into the tube hole; inserting the plurality of electrodes into the plurality of electrode holes; applying a resin to the chamber; removing the tube from the tube hole, wherein removing the tube from the tube hole exposes a sensing zone that allows the plurality of electrodes to be in contact with the fluid.